[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100655170":3},{"organization":4,"outcomesModule":7,"designInfo":19,"detailedDescription":22,"studyPopulation":23,"armGroups":11,"interventions":24,"overallOfficials":11,"centralContacts":29,"locations":35,"responsibleParty":53,"collaborators":11,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":11,"enrollmentInfo":67,"targetDuration":70,"studyType":71,"phases":11,"briefSummary":72,"conditions":73,"keywords":11,"overallStatus":38,"whyStopped":11,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Wroclaw Medical University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Sinus bradycardia \u003C50 beats\u002Fmin on arrival at the recovery unit, defined as a sinus heart rate \u003C50 beats\u002Fmin on the first ECG obtained upon arrival",null,"Day 1",[14,16],{"measure":15,"description":11,"timeFrame":12},"Bradycardia requiring medical intervention",{"measure":17,"description":11,"timeFrame":18},"Sinus bradycardia \u003C50 beats\u002Fmin, defined as a sinus heart rate \u003C50 beats\u002Fmin on the ECG obtained the next day after ablation","Day 2",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":20,"timePerspective":21,"maskingInfo":11},"COHORT","PROSPECTIVE","The following factors will be analyzed:\n\n* demographics\n* medical history\n* medications\n* echocardiographic data\n* baseline ECG\n* anaesthetic records\n* periprocedural data","Consecutive patients undergoing PVI using PFA for the treatment of atrial fibrillation.",[25],{"type":26,"name":27,"description":28,"armGroupLabels":11,"otherNames":11},"PROCEDURE","Pulmonary vein isolation","Ablation of atrial fibrillation using pulsed field technology under general sedation.",[30],{"name":31,"role":32,"phone":33,"phoneExt":11,"email":34},"Piotr Niewinski, MD PhD","CONTACT","+48790423298","pnsky@wp.pl",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Institute of Heart Diseases, Wroclaw Medical University","RECRUITING","Wroclaw","Lower Silesian Voivodeship","50-556","Poland","PL",{"type":45,"coordinates":46},"Point",[47,48],17.03006,51.10286,{"lat":48,"lon":47},[51],{"name":31,"role":32,"phone":11,"phoneExt":11,"email":52},"pnsky1@gmail.com",{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Piotr Niewinski, MD","Doctor","100655170","evaluation-of-the-factors-associated-with-bradycardia-following-pulmonary-vein-isolation-using-pulsed-field-ablation-100655170",false,"NCT07809347","Evaluation of the Factors Associated With BRADYcardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation","Evaluation of the Factors Associated With Bradtycardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation","BRADY-PFA","Inclusion Criteria:\n\n\\- Pulmonary vein isolation performed with PFA\n\nExclusion Criteria:\n\n* Permanent pacemaker\n* CRT device\n* Dual-chamber ICD\n* Cardiac tamponade\n* Acute stroke\n* Acute bleeding requiring surgical intervention","ALL","18 Years",{"count":68,"type":69},100,"ESTIMATED","7 Days","OBSERVATIONAL","The study aims to identify factors associated with bradycardia during the hospital stay after ablation of atrial fibrillation performed with pulsed field technology.",[74,75,76],"Atrial Fibrillation (AF)","Pulsed Field Ablation","Bradycardia","2026-09-03",{"date":79,"type":80},"2026-09-09","ACTUAL",{"date":82,"type":80},"2026-01-01",{"date":84,"type":69},"2026-12-31",{"name":5,"class":6},1]